Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ProtegeRX is a prescription-strength prenatal multivitamin and mineral supplement designed to provide comprehensive nutritional support for women during pregnancy and the postnatal period. Developed by Method Pharmaceuticals, it is specifically formulated to meet the increased metabolic and nutritional requirements of both the mother and the developing fetus. The supplement contains a blend of essential vitamins and minerals, including L-methylfolate, which is the bioactive form of folic acid that supports neural tube development and DNA synthesis, particularly in individuals with MTHFR gene variations. Additionally, it provides iron to support the expansion of maternal blood volume and prevent iron-deficiency anemia, along with other key nutrients like Vitamin D3, B-complex vitamins, and zinc to promote overall fetal growth and maternal well-being.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ProtegeRX.